The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain

BJU Int. 2007 Feb;99(2):243-4. doi: 10.1111/j.1464-410X.2006.06552.x.
No abstract available

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Anilides / adverse effects*
  • Anilides / antagonists & inhibitors
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Gynecomastia / chemically induced
  • Gynecomastia / drug therapy*
  • Humans
  • Male
  • Nitriles
  • Pain / chemically induced
  • Pain / prevention & control*
  • Prostatic Neoplasms / drug therapy
  • Tamoxifen / therapeutic use*
  • Tosyl Compounds / adverse effects*
  • Tosyl Compounds / antagonists & inhibitors
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Anilides
  • Antineoplastic Agents, Hormonal
  • Nitriles
  • Tosyl Compounds
  • Tamoxifen
  • bicalutamide